Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
BMRN
BMRN News & Events
-
Add to Watchlist
Trade BMRN
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
BMRN News
Emerging Trends in Rare Disease Drug Development
5d ago
CNBC
BioMarin Q1 Earnings: Amicus Acquisition Fuels Growth
May 05 2026
seekingalpha
BioMarin Reports Significant Revenue Growth in Q1 2026
May 04 2026
PRnewswire
VOXZOGO Shows Positive Long-Term Effects on Children's Bone Health
May 02 2026
PRnewswire
New Research on VOXZOGO in Children with Achondroplasia
May 02 2026
Newsfilter
BioMarin Pharmaceutical Q1 Earnings Announcement Scheduled
May 01 2026
seekingalpha
BioMarin Acquires Amicus for $4.8 Billion to Enhance Rare Disease Portfolio
Apr 27 2026
PRnewswire
Intellia's Gene Editing Therapy Trial Achieves Success
Apr 27 2026
CNBC
Show More News
BMRN Events
No data
BMRN Monitor News
BioMarin Reports Q1 2026 Revenue Growth and Guidance Upgrade
May 05 2026
BioMarin to Host Q4 2025 Earnings Call on February 23, 2026
Feb 19 2026
BioMarin to Host Q4 2025 Earnings Call on February 23, 2026
Feb 18 2026
BioMarin to acquire Amicus for $4.8 billion
Dec 19 2025
BMRN Earnings Analysis
BioMarin 2025 Earnings: Accelerated Growth Insights- Intellectia AI™
6 months ago
BioMarin Earnings: 2024 Strength Fuels 2025 Growth- Intellectia AI™
1 years ago
BioMarin Pharmaceutical Inc Announces Third Quarter 2024 Financial Results
1 years ago
People Also Watch
